However, TRADD is expressed at high levels in GBM (Glioblastoma multiforme) where it is detected in both the cytoplasm and the nucleus10, and silencing of TRADD in glioma cells resulted in increased sensitivity to TMZ (Temozolomide) by regulating NF-κB, suggesting that cytoplasmic TRADD is a key driver of NF-κB activation in GBM. Here, NFKB1 is linked to glioma.